• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒阴性宫颈癌中的p53突变

p53 mutations in HPV-negative cervical carcinoma.

作者信息

Park D J, Wilczynski S P, Paquette R L, Miller C W, Koeffler H P

机构信息

Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.

出版信息

Oncogene. 1994 Jan;9(1):205-10.

PMID:8302581
Abstract

Human papillomavirus (HPV) infection has been strongly linked to the development of cervical carcinoma. Two viral oncoproteins, E6 and E7, produced by HPV, have been shown to immortalize primary human genital epithelial cells by interacting with the protein products of cellular tumor suppressor genes p53 and Rb, respectively. E6 binds to the cellular p53 protein promoting p53 degradation and inactivity. This mechanism has been suggested to contribute to the oncogenesis of HPV-positive anogenital cancers. In HPV-negative cervical carcinoma, p53 mutation is thought to be the possible mechanism of oncogenesis. We have studied 257 cervical carcinoma specimens for HPV infection by Southern blot analysis and polymerase chain reaction (PCR). Of 257 samples, 39 were HPV-negative. We have further studied 21 HPV-negative specimens for p53 mutations utilizing PCR amplification of genomic DNA followed by single-stranded conformation polymorphism (SSCP) analysis and DNA sequencing. We found only two missense point mutations of p53 gene. In summary, although inactivation of p53 mediated either by E6 or by mutations may be an important key step in the development of cervical carcinoma, our study suggests that other mechanisms may also be involved in development of cervical cancer.

摘要

人乳头瘤病毒(HPV)感染与宫颈癌的发生密切相关。HPV产生的两种病毒癌蛋白E6和E7,已被证明分别通过与细胞肿瘤抑制基因p53和Rb的蛋白质产物相互作用,使原代人泌尿生殖上皮细胞永生化。E6与细胞p53蛋白结合,促进p53降解并使其失活。有人认为这种机制有助于HPV阳性肛门生殖器癌的肿瘤发生。在HPV阴性的宫颈癌中,p53突变被认为是可能的肿瘤发生机制。我们通过Southern印迹分析和聚合酶链反应(PCR)研究了257例宫颈癌标本中的HPV感染情况。在257个样本中,39个为HPV阴性。我们利用基因组DNA的PCR扩增,随后进行单链构象多态性(SSCP)分析和DNA测序,对21个HPV阴性标本进一步研究了p53突变情况。我们仅发现了p53基因的两个错义点突变。总之,尽管由E6介导或由突变介导的p53失活可能是宫颈癌发生过程中的一个重要关键步骤,但我们的研究表明,其他机制也可能参与宫颈癌的发生。

相似文献

1
p53 mutations in HPV-negative cervical carcinoma.人乳头瘤病毒阴性宫颈癌中的p53突变
Oncogene. 1994 Jan;9(1):205-10.
2
Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.人乳头瘤病毒感染阳性和阴性的原发性宫颈癌中p53基因的改变
Cancer Res. 1992 Oct 1;52(19):5323-8.
3
Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.与HPV - 33感染相关的人类宫颈癌中p53突变的存在。
Anticancer Res. 1992 Nov-Dec;12(6B):1989-94.
4
The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.印度子宫颈癌中人乳头瘤病毒及肿瘤抑制基因p53和p16的状况
Gynecol Oncol. 1998 Jun;69(3):205-9. doi: 10.1006/gyno.1998.4991.
5
Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.子宫颈癌细胞系中HPV阳性与p53基因状态之间的相关性。
Gynecol Oncol. 1993 Jan;48(1):104-9. doi: 10.1006/gyno.1993.1016.
6
The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.原发性人宫颈癌中p53的状态及其在人乳头瘤病毒永生化人宫颈细胞中的作用。
Oncogene. 1993 Jun;8(6):1511-8.
7
[Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].宫颈癌中的人乳头瘤病毒、人巨细胞病毒和p53基因
Zhonghua Fu Chan Ke Za Zhi. 1995 Nov;30(11):654-7.
8
Carcinoma of the vulva: HPV and p53 mutations.外阴癌:人乳头瘤病毒与p53突变
Oncogene. 1994 Jun;9(6):1655-9.
9
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.与癌症相关的人类乳头瘤病毒所编码的癌蛋白的细胞靶点。
Princess Takamatsu Symp. 1991;22:239-48.
10
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.原发性宫颈癌中TP53基因的遗传改变、p53蛋白表达及人乳头瘤病毒感染
J Pathol. 1993 Oct;171(2):105-14. doi: 10.1002/path.1711710207.

引用本文的文献

1
Metabolomic profiling reveals grade-specific niacinamide accumulation and its therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer progression.代谢组学分析揭示了特定分级的烟酰胺积累及其通过SIRT1-CD38-EMT轴调节在宫颈癌进展中的治疗潜力。
Biochim Biophys Acta Mol Cell Res. 2025 Oct;1872(7):119994. doi: 10.1016/j.bbamcr.2025.119994. Epub 2025 Jun 1.
2
Co-Delivery of Restored and Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions.聚(β-氨基酯)复合纳米颗粒用于共递送修复和靶向核酸以治疗人乳头瘤病毒相关宫颈病变
Front Pharmacol. 2022 Feb 4;13:826771. doi: 10.3389/fphar.2022.826771. eCollection 2022.
3
PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation.
PARP1抑制使宫颈癌细胞系对放化疗和热放疗敏感。
Cancers (Basel). 2021 Apr 26;13(9):2092. doi: 10.3390/cancers13092092.
4
Regulation of the Human Papillomavirus Life Cycle by DNA Damage Repair Pathways and Epigenetic Factors.DNA 损伤修复途径和表观遗传因素对人乳头瘤病毒生命周期的调控。
Viruses. 2020 Jul 10;12(7):744. doi: 10.3390/v12070744.
5
E2F1-directed activation of nc886 mediates drug resistance in cervical cancer cells via regulation of major vault protein.E2F1 介导的 nc886 激活通过调节主要穹窿蛋白介导宫颈癌细胞的耐药性。
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9233-9242. eCollection 2017.
6
A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.一大系列宫颈和阴道胃型腺癌的详细免疫组织化学分析
Am J Surg Pathol. 2016 May;40(5):636-44. doi: 10.1097/PAS.0000000000000578.
7
The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas.致癌性人乳头瘤病毒(HPV)和p53基因突变在宫颈腺癌中的致癌作用。
Med Oncol. 2006;23(1):113-9. doi: 10.1385/MO:23:1:113.
8
Activation of p53 in cervical carcinoma cells by small molecules.小分子激活宫颈癌细胞中的p53
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8501-6. doi: 10.1073/pnas.97.15.8501.
9
p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.对放疗难治的复发性头颈部鳞状细胞癌中的p53改变
Br J Cancer. 2000 Jan;82(2):392-8. doi: 10.1054/bjoc.1999.0932.
10
DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas.在子宫颈腺癌中,DCC表达与黏液性分化相关,但与p21(WAF1/Cip1)和p27Kip1的表达变化、细胞凋亡、细胞增殖及人乳头瘤病毒感染无关。
Br J Cancer. 1999 Apr;80(1-2):51-8. doi: 10.1038/sj.bjc.6690320.